Mastering Breast Cancer Genetics and Genomics: 3-Part Educational Webinar Series

Welcome to the 3-Part Webinar Series centered around the entire genetics and genomics landscape in Breast Cancer, covering patients at high risk, those who are newly diagnosed, undergoing treatment, or in survivorship. This series will equip you with the expertise to seamlessly integrate genetic and genomic testing into your clinical practice.

Mastering Breast Cancer Genetics and Genomics

Welcome to the 3-Part Webinar Series centered around the entire genetics and genomics landscape in Breast Cancer, covering patients at high risk, those who are newly diagnosed, undergoing treatment, or in survivorship. This series will equip you with the expertise to seamlessly integrate genetic and genomic testing into your clinical practice.

 

Foundations and Application of Germline Testing

In Part One, we will delve into the Foundations and Applications of Germline Testing. Join us as we engage with experts in the field, including Jennifer Lazzara, DNP, ARNP, CGRA, who leads a Breast Cancer Genetics Clinic at Cancer Care Northwest, and Laura Brzeskiewicz, CGC, and Medical Science Liaison Manager at Myriad Genetics.

 

Part 2 – Breast Cancer Risk Assessment and High-Risk Management

In Part 2 of our 3-Part series exploring the comprehensive genetics and genomics landscape in breast cancer, we’ll dive into Risk Assessment and High-Risk Management. Come along as we explore strategies and tests to assess breast cancer risk and tools for implementing a high-risk breast program in your practice. Let’s identify patients together who are at high risk for breast cancer so we can #BeatBreastCancer.

Treatment and Management Utilizing Genomic Testing

Coming soon

Evolving Strategies in Genetics and Genomics 2024

Objectives

  • Summarize recent literature in reproductive and oncology genetics. 
  • Examine universal germline testing utilization for management in breast cancer. 
  • Evaluate the barriers and benefits of universal somatic and germline testing in oncology practice. 
  • Identify the challenges of unexpected findings identified by reproductive genetic screening. 
  • Illustrate how imaging can play a critical role following identification of unexpected results in prenatal cell-free DNA screening

Topic: Updates to Cancer Risk and Clinical Guidance for Germline Variation in CHEK2

Register for Tuesday, Feb 27th at 12:00 PM EST
Register for Thursday, Feb 29th at 3:00 PM EST

Unable to attend live? The recordings will be posted here after the live event.